Solution conformations of the substrates and inhibitor of hepatitis C virus NS3 protease

被引:0
|
作者
Lee, JH
Bang, K
Jung, JW
Ahn, IA
Ro, S
Lee, W
机构
[1] Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120740, South Korea
[2] LG Chem, Biotech Res Inst, Taejon 305380, South Korea
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Hepatitis C virus (HCV) has been known to be an enveloped virus with a positive strand RNA genome and the major agent of the vast majority of transfusion associated cases of hepatitis. For viral replication, HCV structural proteins are first processed by host cell signal peptidases and NS2/NS3 site of the nonstructural protein is cleaved by a zinc-dependent protease NS2 with N-terminal NS3. The four remaining junctions are cleaved by a separate NS3 protease. The solution conformations of NS4B/5A, NS5A/5B substrates and NS5A/5B inhibitor have been determined by two-dimensional nuclear magnetic resonance (NMR) spectroscopy. NMR data suggested that the both NS5A/5B substrate and inhibitor appeared to have a folded turn-like conformation not only between P1 and P6 position but also C-terminal region, whereas the NS4B/5A substrate exhibited mostly extended conformation. In addition, we have found that the conformation of the NS5A/5B inhibitor slightly differs from that of NS5A/5B substrate peptide, suggesting different binding mode for NS3 protease. These findings will be of importance for designing efficient inhibitor to suppress HCV processing.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 50 条
  • [21] Redesigning the substrate specificity of the hepatitis C virus NS3 protease
    Failla, CM
    Pizzi, E
    DeFrancesco, R
    Tramontano, A
    FOLDING & DESIGN, 1996, 1 (01): : 35 - 42
  • [22] A ribonuclease zymogen activated by the NS3 protease of the hepatitis C virus
    Johnson, R. J.
    Lin, Shawn R.
    Raines, Ronald T.
    FEBS JOURNAL, 2006, 273 (23) : 5457 - 5465
  • [23] IDENTIFICATION OF THE PROTEASE DOMAIN IN NS3 OF HEPATITIS-C VIRUS
    HAN, DS
    HAHM, B
    RHO, HM
    JANG, SK
    JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 985 - 993
  • [24] Hepatitis C virus NS3/4a protease inhibitors
    McCauley, John A.
    Rudd, Michael T.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 84 - 92
  • [25] Molecular models of NS3 protease variants of the Hepatitis C virus
    da Silveira, NJF
    Arcuri, HA
    Bonalumi, CE
    de Souza, FP
    Mello, IMVGC
    Rahal, P
    Pinho, JRR
    de Azevedo, WF
    BMC STRUCTURAL BIOLOGY, 2005, 5
  • [26] Allosteric Inhibitors of the NS3 Protease from the Hepatitis C Virus
    Abian, Olga
    Vega, Sonia
    Sancho, Javier
    Velazquez-Campoy, Adrian
    PLOS ONE, 2013, 8 (07):
  • [27] Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease
    Zhang, RM
    Durkin, JP
    Windsor, WT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) : 1005 - 1008
  • [28] Hepatitis C Virus NS3 Protease Is Activated by Low Concentrations of Protease Inhibitors
    Dahl, Goran
    Arenas, Omar Gutierrez
    Danielson, U. Helena
    BIOCHEMISTRY, 2009, 48 (48) : 11592 - 11602
  • [29] Synthesis of Grazoprevir, a Potent NS3/4a Protease Inhibitor for the Treatment of Hepatitis C Virus
    Xu, Feng
    Kim, Jungchul
    Waldman, Jacob
    Wang, Tao
    Devine, Paul
    ORGANIC LETTERS, 2018, 20 (22) : 7261 - 7265
  • [30] Preclinical Characterization of the Novel Hepatitis C Virus NS3 Protease Inhibitor GS-9451
    Yang, Huiling
    Robinson, Margaret
    Corsa, Amoreena C.
    Peng, Betty
    Cheng, Guofeng
    Tian, Yang
    Wang, Yujin
    Pakdaman, Rowchanak
    Shen, Marian
    Qi, Xiaoping
    Mo, Hongmei
    Tay, Chin
    Krawczyk, Steve
    Sheng, X. Christopher
    Kim, Choung U.
    Yang, Chris
    Delaney, William E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 647 - 653